MARC details
000 -LEADER |
fixed length control field |
04882naaaa2201237uu 4500 |
001 - CONTROL NUMBER |
control field |
https://directory.doabooks.org/handle/20.500.12854/68373 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220714160731.0 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
books978-3-03943-978-2 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783039439775 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783039439782 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.3390/books978-3-03943-978-2 |
Terms of availability |
doi |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
English |
042 ## - AUTHENTICATION CODE |
Authentication code |
dc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
M |
Source |
bicssc |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Costantini, Susan |
Relator code |
edt |
9 (RLIN) |
1570695 |
245 10 - TITLE STATEMENT |
Title |
New Prognostic and Predictive Markers in Cancer Progression |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Basel, Switzerland |
Name of publisher, distributor, etc |
MDPI - Multidisciplinary Digital Publishing Institute |
Date of publication, distribution, etc |
2021 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 electronic resource (294 p.) |
506 0# - RESTRICTIONS ON ACCESS NOTE |
Terms governing access |
Open Access |
Source of term |
star |
Standardized terminology for access restriction |
Unrestricted online access |
520 ## - SUMMARY, ETC. |
Summary, etc |
Biomarkers are of critical medical importance for oncologists, allowing them to predict and detect disease and to determine the best course of action for cancer patient care. Prognostic markers are used to evaluate a patient's outcome and cancer recurrence probability after initial interventions such as surgery or drug treatments and, hence, to select follow-up and further treatment strategies. On the other hand, predictive markers are increasingly being used to evaluate the probability of benefit from clinical intervention(s), driving personalized medicine. Evolving technologies and the increasing availability of "multiomics" data are leading to the selection of numerous potential biomarkers, based on DNA, RNA, miRNA, protein, and metabolic alterations within cancer cells or tumor microenvironment, that may be combined with clinical and pathological data to greatly improve the prediction of both cancer progression and therapeutic treatment responses. However, in recent years, few biomarkers have progressed from discovery to become validated tools to be used in clinical practice. This Special Issue comprises eight review articles and five original studies on novel potential prognostic and predictive markers for different cancer types. |
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
Terms governing use and reproduction |
Creative Commons |
-- |
https://creativecommons.org/licenses/by/4.0/ |
-- |
cc |
-- |
https://creativecommons.org/licenses/by/4.0/ |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Medicine |
Source of heading or term |
bicssc |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
MSI2 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
OSCC |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
oral cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
musashi 2 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
prognosis |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
N-cadherin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
EMT |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
breast cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
new metastasis |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
eribulin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
blood |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
biomarker |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bladder cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immune checkpoint inhibitor |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CD8+ T effector cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
microRNA |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
biomarkers |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
head and neck cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
laryngeal cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
prediction |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
metastasis |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
lifestyle habit |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
chemo-/radio resistance |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
therapeutic target |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
AKT |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
AR |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
castration-resistant prostate cancer (CRPC) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
MAPK |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
mTOR |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PI3K |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
prostate cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
therapeutic resistance |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
WNT |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
miRNA |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
melanoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
melanoma resistance to MAPK/MEK inhibitors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
resistance to immune checkpoint inhibitors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
TNBC |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
BRCA1/2 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
HRR |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PDL1 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
TILs |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PI3KCA |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PTEN |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CTCs |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CSC |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
pancreatic cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
K-RAS oncogene |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
oncogene dependency |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
targeted therapies |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
genomic mutations |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
transcriptomics |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
metabolomics |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
selenoproteins |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
HUB nodes |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
major histocompatibility complex (MHC) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
human leukocyte antigen (HLA) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
antigen processing machinery (APM) molecules |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
carcinogenesis |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tumor predisposition |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer immunotherapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
pheochromocytoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
paraganglioma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
head and neck neoplasms |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
head and neck tumors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
genetic syndromes |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
mutations |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hyperglycemia |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cardioncology |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
nivolumab |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cytokines |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cardiotoxicity |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
acetyltransferase |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer prognosis |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
NAA10 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
n/a |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Budillon, Alfredo |
Relator code |
edt |
9 (RLIN) |
1570696 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Costantini, Susan |
Relator code |
oth |
9 (RLIN) |
1570695 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Budillon, Alfredo |
Relator code |
oth |
9 (RLIN) |
1570696 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/3386">https://mdpi.com/books/pdfview/book/3386</a> |
-- |
0 |
Public note |
DOAB: download the publication |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/68373">https://directory.doabooks.org/handle/20.500.12854/68373</a> |
-- |
0 |
Public note |
DOAB: description of the publication |